USP33 and hepatocellular carcinoma: Unlike USP33, which has been reported to inhibit mitogen-activated protein kinase (MAPK) activation pathway and suppress hepatoma cell growth26, our study suggests that USP21 activates ERK1/2 to promote HCC cell proliferation.